The NΔecd-tumor transcriptome contains most core components of the JNK pathway, but shows no evidence of increased JNK activity e.g., upregulation of puc or Mmp1 (48) in the allografts vs. primary tumors. This evidence concerns the gene MMP1 and neoplasm.